Autoimunitate
Listă analize medicale - categoria Autoimunitate
| AMA - anticorpi anti-mitocondriali (AMA)** | 201 | 181 | 1400 |
| AMA-M2 (AMA2)* | 85 | 77 | 1736 |
| AMA-M9 (AMA9)* | 105 | 95 | 3282 |
| Amiloid A in ser (SAA)* | 125 | 113 | 2942 |
| ANA - PANEL 23 ANTIGENE NUCLEARE BLOT EXTINS (ADNds, nucleosome, histone, SS-A, Ro52, SS-B, nRNP/Sm, Mi-2 beta, Mi-2 alfa, Ku, CENP A, CENP B, Sp100, PML, Scl 70, PM-Scl 100, PM-Scl 75, RP 11, RP 155, gp 210, PCNA, DFS 70)** | 275 | 248 | 4822 |
| ANA - PANEL 3 BLOT EXTINS (U1nRNP, Sm, SS-A, Ro52, SS-B, Scl-70, Pm-Scl, Jo-1, Centromer B, PCNA, ADNds, Nucleosom, Histone, Proteina P ribosomala, AMA-M2, DFS-70)** | 200 | 180 | 4776 |
| ANA - screening Ac IgG - Imunofluorescenta** | 68 | 61 | 2615 |
| ANA - screening si titrare Ac IgG - Imunofluorescenta** | 106 | 95 | 1290 |
| ANA - titrare Ac IgA, IgG, IgM - Imunofluorescenta** | 235 | 212 | 5695 |
| ANCA (cANCA+pANCA)* | 231 | 208 | 1371 |
| Anti Receptor TSH (TRAB)** | 142 | 128 | 612 |
| Anti-asialoglicoprotein receptor (ASGP-R)* | 130 | 117 | 5836 |
| Anti-IgLON5 in LCR (IGL5IL)* | 245 | 221 | 5885 |
| Anti-IgLON5 in ser (IGLO5I)* | 310 | 279 | 5811 |
| Anticorpi anti - mGluR5 - IgG (MGLUR5)* | 105 | 95 | 5770 |
| Anticorpi anti acetilcolin receptor (ACRH)* | 182 | 164 | 1453 |
| Anticorpi anti acini de glanda salivara (SPEIAZ)* | 94 | 85 | 2071 |
| Anticorpi anti actina (ACTA)* | 110 | 99 | 2116 |
| Anticorpi anti ADN dublu catenar-DS (DDNSE)* | 88 | 79 | 1307 |
| Anticorpi anti ADN dublu catenar-DS in LCR (DDNSEL)* | 132 | 119 | 2752 |
| Anticorpi anti ADN monocatenar-SS (SDNSE)* | 109 | 98 | 1449 |
| Anticorpi anti adreno-cortex (NNA)* | 105 | 95 | 1692 |
| Anticorpi anti Agrin IgG (AGRING)* | 170 | 153 | 5921 |
| Anticorpi anti Amfifizina (AMPHI1)* | 250 | 225 | 5878 |
| Anticorpi anti Amfifizina 1 in LCR (AMPH1L)* | 250 | 225 | 5867 |
| Anticorpi anti Annexin V IgG (ANNV)* | 110 | 99 | 1902 |
| Anticorpi anti BPI (proteine ce cresc permeabilitatea bactericida) (BPI)* | 135 | 122 | 5902 |
| Anticorpi anti canal de calciu tip N in LCR (CAKNL)* | 330 | 297 | 2745 |
| Anticorpi anti canal de calciu tip PQ in LCR (CAKPQL)* | 330 | 297 | 2746 |
| Anticorpi anti canale de potasiu in LCR (KKAKL)* | 220 | 198 | 5813 |
| Anticorpi anti canale de potasiu voltaj-dependente (KKAK)* | 259 | 233 | 2158 |
| Anticorpi anti Cardiolipina IgA* | 150 | 135 | 6097 |
| Anticorpi anti Cardiolipina IgG, IgM* | 145 | 131 | 6096 |
| Anticorpi anti CASPR2 (Contactin-associated protein 2) in LCR (CASPRL)* | 245 | 221 | 5870 |
| Anticorpi anti CASPR2 (Contactin-associated protein 2) in ser (CASPR2)* | 250 | 225 | 5931 |
| Anticorpi anti catepsina G (CATG)* | 115 | 104 | 5915 |
| Anticorpi anti CCP - Peptidul ciclic citrulinat** | 140 | 126 | 1392 |
| Anticorpi anti celula endoteliala (EZA)* | 145 | 131 | 2203 |
| Anticorpi anti celule insulare (ICAT)* | 312 | 281 | 1504 |
| Anticorpi anti celule parietale gastrice (PARIA)** | 183 | 165 | 1606 |
| Anticorpi anti citocrom P450-c17-hidroxilaza (PC17H)* | 105 | 95 | 2405 |
| Anticorpi anti citocrom P450-scc-hidroxilaza (PSCCH)* | 90 | 81 | 2404 |
| Anticorpi anti colagen tip VII IgG (KOLL7)* | 115 | 104 | 5789 |
| Anticorpi anti Contactin 1 in LCR (CNTN1L)* | 281 | 253 | 5117 |
| Anticorpi anti Contactin 1 in ser (CASPR1)* | 282 | 254 | 5116 |
| Anticorpi anti CRMP5 in LCR (Oligodendrocite) (CRMP5L)* | 145 | 131 | 2584 |
| Anticorpi anti CRMP5 in ser (Oligodendrocite) (CRMP5)* | 143 | 129 | 2585 |
| Anticorpi anti CV-2 in LCR (CV2L)* | 250 | 225 | 5794 |
| Anticorpi anti desmozom (pemfigus) (STAK)* | 330 | 297 | 2491 |
| Anticorpi anti DFS 70 (DFS70)* | 121 | 109 | 3588 |
| Anticorpi anti Endomysium IgA (EMAA)* | 127 | 114 | 1526 |
| Anticorpi anti Endomysium IgG (EMAG)* | 182 | 164 | 1527 |
| Anticorpi anti Endomysium IgM* | 132 | 119 | 4426 |
| Anticorpi anti enterocitari (AIE)* | 209 | 188 | 2267 |
| Anticorpi anti epiteliu acini de glanda salivara (SPEIBA)* | 105 | 95 | 2072 |
| Anticorpi anti factor intrinsec** | 349 | 314 | 1518 |
| Anticorpi anti fodrin (spectrina non-eritroida) IgA (FODAE)* | 120 | 108 | 2572 |
| Anticorpi anti fodrin (spectrina non-eritroida) IgG (FODGE)* | 120 | 108 | 2573 |
| Anticorpi anti fosfatidil-etanolamina IgG (PHETG)* | 65 | 59 | 2720 |
| Anticorpi anti fosfatidil-etanolamina IgM (PHETM)* | 65 | 59 | 2721 |
| Anticorpi anti fosfatidil-glicerol IgG (PHGLG)* | 78 | 70 | 3363 |
| Anticorpi anti fosfatidil-glicerol IgM (PHGLM)* | 78 | 70 | 3323 |
| Anticorpi anti fosfatidil-inozitol IgG (PHING)* | 78 | 70 | 3119 |
| Anticorpi anti fosfatidil-inozitol IgM (PHINM)* | 90 | 81 | 3120 |
| Anticorpi anti fosfatidil-serina IgA (PHSEA)* | 115 | 104 | 5729 |
| Anticorpi anti fosfatidil-serina IgG (PHSEG)* | 115 | 104 | 5730 |
| Anticorpi anti fosfatidil-serina IgM (PHSEM)* | 115 | 104 | 5731 |
| Anticorpi anti Fosfolipidici IgG* | 77 | 69 | 1326 |
| Anticorpi anti Fosfolipidici IgM* | 77 | 69 | 1777 |
| Anticorpi anti gangliozide-mielina 1 IgG (GM1G)* | 160 | 144 | 2812 |
| Anticorpi anti gangliozide-mielina 1 IgG in LCR (GMGL)* | 106 | 95 | 2780 |
| Anticorpi anti gangliozide-mielina 1 IgM (GM1M)* | 160 | 144 | 2813 |
| Anticorpi anti gangliozide-mielina 1 IgM in LCR (GMML)* | 106 | 95 | 2781 |
| Anticorpi anti gangliozide-mielina 2 IgG (GM2G)* | 106 | 95 | 3075 |
| Anticorpi anti gangliozide-mielina 2 IgM (GM2M)* | 106 | 95 | 3076 |
| Anticorpi anti Glicoproteina oligodendrocitara a mielinei (MOGI)** | 250 | 225 | 5907 |
| Anticorpi anti Glicoproteina oligodendrocitara a mielinei in LCR (MOGIL)* | 245 | 221 | 5879 |
| Anticorpi anti GM-CSF (Granulocite-Macrofage)* | 150 | 135 | 6017 |
| Anticorpi anti Haemophilus influenzae tip B IgG postvaccinali (HIBGE)* | 200 | 180 | 5097 |
| Anticorpi anti hialuronidaza (AHYA)* | 109 | 98 | 5749 |
| Anticorpi anti Hu-D (HU)* | 105 | 95 | 1888 |
| Anticorpi anti Hu-D in LCR - BLOT (HUBL)* | 200 | 180 | 5732 |
| Anticorpi anti Hu-D in LCR (HUL)* | 105 | 95 | 2703 |
| Anticorpi anti Jo-1 (JO1)* | 97 | 87 | 1710 |
| Anticorpi anti Ku (KUB)* | 198 | 178 | 1813 |
| Anticorpi anti LC1 (LC1)* | 178 | 160 | 5364 |
| Anticorpi anti LGI1 in LCR (LGI1L)* | 330 | 297 | 5812 |
| Anticorpi anti LGI1 in ser (encefalita limbica) (LGI1)* | 330 | 297 | 5795 |
| Anticorpi anti MDA5 - BLOT (MDA5B)* | 106 | 95 | 4691 |
| Anticorpi anti membrana bazala alveolara (ALVBA)* | 98 | 88 | 3297 |
| Anticorpi anti membrana bazala epidermala (EBMA)* | 213 | 192 | 2414 |
| Anticorpi anti membrana bazala glomerulara (GBMC)* | 97 | 87 | 5688 |
| Anticorpi anti Mi 2 (MI2)* | 143 | 129 | 1811 |
| Anticorpi anti microzomiali - LKM1* | 96 | 86 | 1283 |
| Anticorpi anti mielina asociata glycoproteinei IgM in LCR (MAGL)* | 250 | 225 | 5871 |
| Anticorpi anti miocard (HMA)* | 271 | 244 | 1929 |
| Anticorpi anti muschi cardiac* | 200 | 180 | 6055 |
| Anticorpi anti muschi neted (ASMA)* | 150 | 135 | 5367 |
| Anticorpi anti muschi striat (SKMA)* | 138 | 124 | 1648 |
| Anticorpi anti MuSK (tirozinkinaza musculara) (RTYRA)* | 230 | 207 | 1914 |
| Anticorpi anti Mycoplasma hominis/Ureaplasma urealyticum IgG** | 138 | 124 | 1586 |
| Anticorpi anti myosin (MYOA)* | 110 | 99 | 1649 |
| Anticorpi anti neurofascin 140 in ser* | 656 | 590 | 5118 |
| Anticorpi anti neurofascin 155 in ser (NF155)* | 293 | 264 | 5528 |
| Anticorpi anti neurofascin 186 in ser (NF186)* | 293 | 264 | 5529 |
| Anticorpi anti Neurofilamente (NEUFI)* | 250 | 225 | 5887 |
| Anticorpi anti Neurofilamente in LCR (NEUFIL)* | 250 | 225 | 5886 |
| Anticorpi anti neuronali - Hu-D, Ri, Yo (NEURO)* | 327 | 294 | 2136 |
| Anticorpi anti neuronali - NMDAR, AMPAR, GABABR, LGI1, CASPR2, GABAAR, mGluR1, mGluR2, mGluR5, DPPX, IGLON5, Neurexin, Gluk2, SEZ6L2 - in LCR * | 1790 | 1611 | 6003 |
| Anticorpi anti neuronali - NMDAR, AMPAR, GABABR, LGI1, CASPR2, GABAAR, mGluR1, mGluR2, mGluR5, DPPX, IGLON5, Neurexin, Gluk2, SEZ6L2* | 1595 | 1436 | 6002 |
| Anticorpi anti neuronali BLOT - Amphiphysin, CV2, PNMA2 (Ma2/Ta), Ri, Yo, Hu, Recoverin, AGNA (SOX1), Titin (MGT - 30)** | 530 | 477 | 5957 |
| Anticorpi anti neuronali CV2 in ser - BLOT (CV2B)* | 149 | 134 | 2968 |
| Anticorpi anti neuronali Ma1 in LCR (MA1L)* | 105 | 95 | 2774 |
| Anticorpi anti neuronali Ma2 in LCR (MA2L)* | 250 | 225 | 5869 |
| Anticorpi anti neuronali Ma2/Ta (MA2)* | 250 | 225 | 5872 |
| Anticorpi anti NOR-90 (NOR90)* | 78 | 70 | 1942 |
| Anticorpi anti nucleotidaza cN-1A IgG (miozita sIBM) (MUP44)* | 138 | 124 | 5513 |
| Anticorpi anti nucleozom (NUCLEC)* | 116 | 104 | 2917 |
| Anticorpi anti ovarieni (OVAK)* | 248 | 223 | 1968 |
| Anticorpi anti PCA-2 in LCR (PCAL)* | 250 | 225 | 5914 |
| Anticorpi anti PDGFR beta (PDGFRB)* | 106 | 95 | 4783 |
| Anticorpi anti pituitari (APA) (HYPA)* | 95 | 86 | 3568 |
| Anticorpi anti PM/Scl (PMSCL)* | 154 | 139 | 1901 |
| Anticorpi anti Pneumococ IgG postvaccinali (Streptococcus pneumoniae anticorpi anti capsula polizaharidica 1-5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 20, 22F, 23F, 33F) (PNGE)* | 110 | 99 | 2839 |
| Anticorpi anti proteina acida gliala fibrilara IgG (GFAPG)* | 300 | 270 | 5847 |
| Anticorpi anti proteina acida gliala fibrilara IgG in LCR (GFAPGL)* | 330 | 297 | 5848 |
| Anticorpi anti proteina bazica a mielinei (MBP)* | 250 | 225 | 5796 |
| Anticorpi anti proteina bazica a mielinei in LCR (MBPL)* | 271 | 244 | 5868 |
| Anticorpi anti Proteina-P ribozomala (RIBGE)* | 201 | 181 | 1960 |
| Anticorpi anti proteine histone (HISTO)* | 236 | 212 | 5790 |
| Anticorpi anti quadrosialo gangliozid IgG (GQ1b) (GQ1BG)* | 106 | 95 | 3129 |
| Anticorpi anti receptor A2-Fosfolipaza IgG (PLA2RE)* | 150 | 135 | 3550 |
| Anticorpi anti receptor AMPA (GluR1, GluR2, AMPA-r) (AMPAR)* | 295 | 266 | 5935 |
| Anticorpi anti receptor AMPA in LCR (AMPARL)* | 121 | 109 | 5939 |
| Anticorpi anti receptor de glicina (GLYCR)* | 260 | 234 | 5793 |
| Anticorpi anti receptor glutamat (NMDA) IgA (NMDARA)* | 250 | 225 | 5797 |
| Anticorpi anti receptor glutamat (NMDA) in LCR (NMDARL)* | 295 | 266 | 2640 |
| Anticorpi anti receptor muscarinic M3 de acetilcolina (ACHM3)* | 220 | 198 | 5963 |
| Anticorpi anti receptor Ryanodin (RYR)* | 121 | 109 | 3183 |
| Anticorpi anti Reticulina IgA* | 135 | 122 | 5641 |
| Anticorpi anti Reticulina IgG* | 135 | 122 | 5642 |
| Anticorpi anti Ri (RI)* | 144 | 130 | 2130 |
| Anticorpi anti Ri in LCR - BLOT (RIBL)* | 200 | 180 | 5733 |
| Anticorpi anti Ri in LCR (RIL)* | 105 | 95 | 2704 |
| Anticorpi anti ribonucleoproteine - U1-RNP/Sm (RNPSM)* | 111 | 100 | 5280 |
| Anticorpi anti Saccharomyces cerevisiae IgA, IgG (ASCA)* | 403 | 363 | 6076 |
| Anticorpi anti Saccharomyces cerevisiae IgM (SCEMI)* | 121 | 109 | 1525 |
| Anticorpi anti Scl 70 (SCL70)* | 100 | 90 | 1410 |
| Anticorpi anti spermatozoizi (SPAK)* | 170 | 153 | 1404 |
| Anticorpi anti SRP (SRP)* | 121 | 109 | 1812 |
| Anticorpi anti SS-A-Ro (SSA)* | 94 | 85 | 1302 |
| Anticorpi anti SS-B-La (SSB)* | 96 | 86 | 1303 |
| Anticorpi anti steroid 21-hidroxilaza (PC21H)* | 213 | 192 | 2134 |
| Anticorpi anti tiroglobulina | 58 | 52 | 623 |
| Anticorpi anti Tirozin-fosfataza (IA2)* | 189 | 170 | 2057 |
| Anticorpi anti Titin (MGT-30) (TITIN)* | 207 | 186 | 2582 |
| Anticorpi anti Tr (TR)* | 220 | 198 | 5901 |
| Anticorpi anti trombocitari legati IgG si IgM (THRAL)* | 187 | 168 | 2401 |
| Anticorpi anti trombocitari liberi - receptori de fibrinogen, von Willebrand si colagen (THRAF)* | 797 | 717 | 2402 |
| Anticorpi anti trombocitari liberi si legati (THROA)* | 770 | 693 | 1631 |
| Anticorpi anti U3-nRNP Fibrilarina (U3RNP)* | 130 | 117 | 1940 |
| Anticorpi anti Vimentina Citrulinata Mutanta (anti-MCV) (MCVAK)* | 165 | 149 | 2314 |
| Anticorpi anti Yo (YO)* | 120 | 108 | 2131 |
| Anticorpi anti Yo in LCR - BLOT (YOBL)* | 200 | 180 | 5734 |
| Anticorpi anti Yo in LCR (YOL)* | 105 | 95 | 2705 |
| Anticorpi anti-beta2 glicoproteina1 - IgA* | 100 | 90 | 6079 |
| Anticorpi anti-beta2 glicoproteina1 - IgG, IgM* | 200 | 180 | 6084 |
| Anticorpi anti-canale de calciu (tip N si PQ)* | 621 | 559 | 6141 |
| Anticorpi anti-desmoglein 1 si 3 (DSG 1 si 3)* | 640 | 576 | 6130 |
| Anticorpi anti-fosfatidilserina IgG/IgM/IgA* | 178 | 160 | 6119 |
| Anticorpi anti-gangliozide (IgG/IgM)* | 518 | 466 | 6091 |
| Anticorpi anti-glicoproteina asociata mielinei (MAG)* | 409 | 368 | 6138 |
| Anticorpi anti-neurocondrina (NEUCH)* | 300 | 270 | 6022 |
| Anticorpi anti-receptor de glicina in LCR (GLYCRL)* | 300 | 270 | 5775 |
| Anticorpi anti-receptor glutamat (tip NMDA) in ser* | 159 | 143 | 6071 |
| Anticorpi anti-RNS polimeraza III* | 280 | 252 | 6163 |
| Anticorpi anti-SLA/LP* | 152 | 137 | 6095 |
| Anticorpi Antinucleari Sm (SM)* | 92 | 83 | 1291 |
| Anticorpi PR3 - Proteinaza 3 (PR3C)* | 83 | 75 | 4468 |
| Aquaporin 4 (Neuromielita optica) Ac IgG** | 245 | 221 | 6006 |
| Aquaporin 4 (Neuromielita optica) Ac totali in LCR** | 500 | 450 | 6007 |
| ATPO - Ac anti tiroperoxidaza | 68 | 61 | 88 |
| Beta Amiloid raport 42/40 in LCR (AMYLIQ)* | 374 | 337 | 2713 |
| c-ANCA - Anticorpi anti citoplasma neutrofilelor PR3 (ANCAC)* | 81 | 73 | 1373 |
| Carboanhidraza 1 Ac (CARB1A)* | 132 | 119 | 1599 |
| Carboanhidraza 2 Ac (CARB2A)* | 295 | 266 | 1600 |
| CIC - complexe imune circulante (C1QBI)* | 73 | 66 | 5745 |
| Crioglobuline** | 40 | 36 | 1304 |
| ENA Panel (Centromer B IgG-Ac, Chromatin (nucl.) Ac, SS-A/Ro, La/SS-B, Sm, RNP, U1-RNP/SM, Scl-70, Jo-1, Ribosomal P-protein Ac) - metoda FCM (AENABP)* | 176 | 158 | 2410 |
| Factor reumatoid - Waaler Rose** | 28 | 25 | 1181 |
| Factor reumatoid (test calitativ)** | 12 | 11 | 106 |
| Factor reumatoid (test cantitativ)* | 32 | 29 | 201 |
| Factor reumatoid IgA, IgM* | 189 | 170 | 6081 |
| Factor reumatoid IgG* | 95 | 86 | 2371 |
| Fetuin A (AHGS) (FETUI)* | 275 | 248 | 5912 |
| Gliadina Ac IgA (GLIAE)* | 78 | 70 | 1485 |
| Gliadina Ac IgA in materii fecale (GLAST)* | 111 | 100 | 1772 |
| Gliadina Ac IgG (GLIGE)* | 78 | 70 | 1486 |
| GP210 Ac (GP210B)* | 130 | 117 | 1738 |
| Hepatita autoimuna BLOT - screening si diferentiere pentru anticorpi AMA-M2, M2-3E (BPO), Sp100, PML, GP210, LKM-1, LC-1, SLA/LP, Ro-52** | 265 | 239 | 5958 |
| HLA screening - Ac Iso HLA (HLAAK)* | 386 | 347 | 3679 |
| HLA screening avansat - Ac Citotoxici anti HLA (HLAPRA)* | 386 | 347 | 3680 |
| NK panel (NKALMZ)* | 1600 | 1440 | 2499 |
| p-ANCA - Anticorpi anti citoplasma neutrofilelor MPO (ANCAP)* | 90 | 81 | 1372 |
| Panel anticorpi antineuronali BLOT (Hu, Ri, Yo, Ma-2, CV-2, Amfifizina 1) (NEUAK)* | 281 | 253 | 4417 |
| Panel anticorpi antineuronali BLOT (Hu, Ri, Yo, Ma-2, CV-2, Amfifizina 1) in LCR (NEUAKL)* | 647 | 582 | 5735 |
| Panel anticorpi Scleroza sistemica progresiva (Ku, PMSCL 100, PMSCL 75, Polimeraza III, Nor-90, U3, Th/To, Centromer A, Centromer B, PDGFR)** | 244 | 220 | 4784 |
| Panel miozita extins - Mi-2a, Mi-2ß, TIF-1Y, MDA5, NXP2, SAE1, Ku, PM-Scl100, PM-Scl75, Jo-1, SRP, PL-7, PL-12, EJ, OJ, RO52 - immunoblot** | 299 | 269 | 5201 |
| Pemfigus bulos - Anticorpi IgG anti AG1 (230 kD) si AG2 (180 kD) (BULLOE)* | 230 | 207 | 5791 |
| Pemfigus bulos - Anticorpi IgG anti AG2 (180 kD) (BP2G)* | 248 | 223 | 5884 |
| SP100 Ac IgG (SP100B)* | 132 | 119 | 5349 |
| Test de citotoxicitate - celule NK in sange-heparinat (NKA)* | 2200 | 1980 | 2549 |
| Test de citotoxicitate - NK-CD57 in sange heparinat (LIDBO)* | 2200 | 1980 | 3015 |
| Transglutaminaza tisulara (tTG) Ac IgA (GTGLAE)** | 90 | 81 | 1488 |
| Transglutaminaza tisulara (tTG) Ac IgG (GTGLGE)** | 85 | 77 | 1412 |
